TrialNature communications2022
Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia.
Rebecca Anderson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
33 papers cite it
this papercites it
TrialNature communications2022
Rebecca Anderson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.